Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Focal Cerebral Arteriopathy Steroid Trial

NCT06040255 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06040255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06040255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Focal Cerebral Arteriopathy Steroid Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
October 1, 2023
Completion date
January 31, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial ischemic stroke, arteriopathy, pediatric stroke